Differences in Expression of Inflammatory Mediator in Mucosal and Polyp Tissue between Chronic Rhinosinusitis and Recurrent Chronic Rhinosinusitis

Authors

  • Effy Huriyati Postgraduate Biomedical Science, Faculty of Medicine, Andalas University, Padang, Indonesia
  • Eryati Darwin Department of Histology, Faculty of Medicine, Andalas University, Padang Indonesia
  • Yanwirasti Yanwirasti Department of Anatomy, Faculty of Medicine, Andalas University, Padang, Indonesia
  • Irza Wahid Department of Internal Medicine, Faculty of Medicine, Andalas University, General Hospital of Dr M. Djamil, Padang, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2019.341

Keywords:

Recurrent CRSwNP, IL-5, IL-8, IL-17A, TGF-β1

Abstract

BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) remains a challenging clinical entity with its propensity for recurrence. This disease decreases the patients’ quality of life and creates a high economic burden. An effort to investigate the aetiology of recurrent polyps have to be more alert.

AIM: This study aims to prove the differences in expression of IL-5, IL-8, IL-17A and TGF-β1 in mucosal and polyp tissue between CRSwNP and recurrent CRSwNP and also to determine which expression of cytokines that have the main role in mucosal and polyp tissue in recurrent CRSwNP.

MATERIAL AND METHODS: An observational study was conducted with a comparative cross-sectional design of CRS patients with 15 recurrent CRSwNP and CRSwNP who had never undergone surgery for as many as 15 polyps. Mucosal specimens of nasal polyps are taken by brushing, and polyp tissue specimens are taken during surgical removal of nasal polyps. Specimens from the polyp mucosa were examined by ELISA while the polyp tissue specimens were carried out immunohistochemistry (IHC).

RESULTS: The result showed that there is a significant difference in IL-5 expression in the polyp mucosal between CRSwNP with recurrent CRSwNP, where expression is higher in recurrent CRSwNP. The expression of IL-8, IL-17 and TGF-β1 were lower in recurrent CRSwNP, but the difference was not significant. In nasal polyp tissue, there is a significant difference in TGF-β1 and IL-8 expression between CRSwNP and recurrent CRSwNP, where the expression of both cytokines is lower in recurrent CRSwNP. Interleukin-5 expression was higher in recurrent CRSwNP than CRSwNP, but the difference was not significant. In the polyps mucosal, IL-5 has the main role in recurrent CRSwNP polyp, whereas TGF-β has the main role in polyp tissue.

CONCLUSION: This study concluded that the expression of IL-5 in the mucosa could be examined with simple techniques like brushing before polypectomy or FESS was performed to determine the possibility of polyps recurrencies.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Van Zele T, Holtappels G, Gevaert P, Bachert C. Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps. American journal of rhinology & allergy. 2014; 28(3):192-8. https://doi.org/10.2500/ajra.2014.28.4033 PMid:24980230

Tomassen P, Van Zele T, Zhang N, Perez-Novo C, Van Bruaene N, Gevaert P, et al. Pathophysiology of chronic rhinosinusitis. Proceedings of the American Thoracic Society. 2011; 8(1):115-20. https://doi.org/10.1513/pats.201005-036RN PMid:21364229

Eloy P, Poirrier AL, De Dorlodot C, Van Zele T, Watelet JB, Bertrand B. Actual concepts in rhinosinusitis: a review of clinical presentations, inflammatory pathways, cytokine profiles, remodeling, and management. Current allergy and asthma reports. 2011; 11(2):146-62. https://doi.org/10.1007/s11882-011-0180-0 PMid:21274665

Rinia AB, Kostamo K, Ebbens FA, van Drunen CM, Fokkens WJ. Nasal polyposis: a cellular-based approach to answering questions. Allergy. 2007; 62(4):348-58. https://doi.org/10.1111/j.1398-9995.2007.01323.x PMid:17362244

Kosem M, Bulut G, Kaya Z. Analysis of Ki-67 Immunoreactivity in Recurring and Nonrecurring Nasal Polyps. Journal of Otolaryngology-Head & Neck Surgery. 2010; 39(4):464-7.

Yeo NK, Eom DW, Oh MY, Lim HW, Song YJ. Expression of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 1 in nonrecurrent vs recurrent nasal polyps. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2013; 111(3):205-10. https://doi.org/10.1016/j.anai.2013.06.023 PMid:23987197

Bachert C, Pawankar R, Zhang L, Bunnag C, Fokkens WJ, Hamilos DL, et al. ICON: chronic rhinosinusitis. World Allergy Organization Journal. 2014; 7(25):2-28. https://doi.org/10.1186/1939-4551-7-25 PMid:25379119 PMCid:PMC4213581

Pawankar R, Nonaka M, Satoru Masuno a, Kimura S. Nasal Polyposis. Current Concepts on the Pathomechanisms of Chronic Rhinosinusitis and Nasal Polyps. Berlin Heidelberg: Springer, 2010:185-8. https://doi.org/10.1007/978-3-642-11412-0_21

Lou H, Zhang N, Bachert C, Zhang L. Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement. International forum of allergy & rhinology. 2018; 8(11):1218-25. https://doi.org/10.1002/alr.22214 PMid:30296011 PMCid:PMC6282610

Wei B, Liu F, Zhang J, Liu Y, Du J, Liu S, et al. Multivariate analysis of inflammatory endotypes in recurrent nasal polyposis in a Chinese population. Rhinology. 2018:216-26. https://doi.org/10.4193/Rhin17.240 PMid:29785413

Tosun F, Arslan HH, Karslioglu Y, Deveci MS, Durmaz A. Relationship between postoperative recurrence rate and eosinophil density of nasal polyps. Annals of Otology, Rhinology & Laryngology. 2010; 119(7):455-9. https://doi.org/10.1177/000348941011900705 PMid:20734966

Suzuki H, Ikedab K. Mode of Action of Long-Term Low-Dose Macrolide Therapy for Chronic Sinusitis in the Light of Neutrophil Recruitment. Current Drug Targets - Inflammation & Allergy. 2002; 1(1):117-26. https://doi.org/10.2174/1568010023344832

Wen W, Liu W, Zhang L, Bai J, Fan Y, Xia W, et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy. The Journal of allergy and clinical immunology. 2012; 129(6):1522-8 e5. https://doi.org/10.1016/j.jaci.2012.01.079 PMid:22460066

Perić A, Vojvodić D, Radulović V. Cytokine Profiles in Nasal Fluid in Patients with Nasal Polyps: A Flow Cytometric Study. Journal of Medical Biochemistry. 2010; 29(1):28-33. https://doi.org/10.2478/v10011-010-0003-1

Ikeda K, Shiozawa A, Ono N, Kusunoki T, Hirotsu M, Homma H, et al. Subclassification of chronic rhinosinusitis with nasal polyp based on eosinophil and neutrophil. The Laryngoscope. 2013; 123(11):E1-9. https://doi.org/10.1002/lary.24154 PMid:23670893

Jiang XD, Li GY, Li L, Dong Z, Zhu DD. The characterization of IL-17A expression in patients with chronic rhinosinusitis with nasal polyps. American journal of rhinology & allergy. 2011; 25(5):e171-5. https://doi.org/10.2500/ajra.2011.25.3645 PMid:22186234

Yang Y, Zhang N, Lan F, Van Crombruggen K, Fang L, Hu G, et al. Transforming growth factor-beta 1 pathways in inflammatory airway diseases. Allergy. 2014; 69(6):699-707. https://doi.org/10.1111/all.12403 PMid:24750111

Balsalobre L, Pezato R, Perez C-N, Alve M, Santos R, Bachert C, et al. Epithelium and stroma from nasal polyp mucosa exhibits inverse expression of TGF-β1 as compared with healthy nasal mucosa. Journal of Otolaryngology - Head and Neck Surgery 2013; 42(29):2-5. https://doi.org/10.1186/1916-0216-42-29 PMid:23663486 PMCid:PMC3651223

Hirschberg A, Jo Ìku Ìti A, Darvas Z, Krisztina A, Ga Ìbor Rps, Andra Ìs F. The Pathogenesis of Nasal Polyposis by Immunoglobulin E and Interleukin-5 Is Completed by Transforming Growth Factor beta1. The Laryngoscope. 2003; 113:120-4. https://doi.org/10.1097/00005537-200301000-00022 PMid:12514394

Van Crombruggen K, Zhang N, Gevaert P, Tomassen P, Bachert C. Pathogenesis of chronic rhinosinusitis: inflammation. The Journal of allergy and clinical immunology. 2011; 128(4):728-32. https://doi.org/10.1016/j.jaci.2011.07.049 PMid:21868076

Matsuwaki Y, Ookushi T, Asaka D, Mori E, Nakajima T, Yoshida T, et al. Chronic rhinosinusitis: risk factors for the recurrence of chronic rhinosinusitis based on 5-year follow-up after endoscopic sinus surgery. International archives of allergy and immunology. 2008; 146 Suppl 1:77-81. https://doi.org/10.1159/000126066 PMid:18504412

Nakayama T, Yoshikawa M, Asaka D, Okushi T, Matsuwaki Y, Otori N, et al. Mucosal eosinophilia and recurrence of nasal polyps - new classification of chronic rhinosinusitis. Rhinology. 2011; 49(4):392-6.

Tecimer SH, Kasapoglu F, Demir UL, Ozmen OA, Coskun H, Basut O. Correlation between clinical findings and eosinophil/neutrophil ratio in patients with nasal polyps. European Archives of Oto-Rhino-Laryngology. 2014; 272(4):915-21. https://doi.org/10.1007/s00405-014-3174-4 PMid:25007735

Published

2019-06-01

How to Cite

1.
Huriyati E, Darwin E, Yanwirasti Y, Wahid I. Differences in Expression of Inflammatory Mediator in Mucosal and Polyp Tissue between Chronic Rhinosinusitis and Recurrent Chronic Rhinosinusitis. Open Access Maced J Med Sci [Internet]. 2019 Jun. 1 [cited 2024 Apr. 20];7(11):1733-8. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2019.341

Issue

Section

A - Basic Science

Most read articles by the same author(s)

1 2 3 > >>